CPIG
EVOK

Chicago Partners Investment Group’s Evoke Pharma EVOK Stock Holding History

Chicago Partners Investment Group’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7
Closed -$2K – 543
2016
Q3 		$2K Buy
+7
New +$3.2K ﹤0.01% 478

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 24.6% 1-Year Est. Return

Chicago Partners Investment Group's EVOK Position: Q4 2016 in Review

Chicago Partners Investment Group sold out of Evoke Pharma (EVOK) in Q4 2016, closing a stake of 7 shares — an estimated $2K sold.

Chicago Partners Investment Group first reported a position in EVOK in Q3 2016 and held it in 1 quarter. The position peaked at $2K in Q3 2016. 14 funds tracked by Wall St. Rank hold EVOK as of Q4 2016.

  • Chicago Partners Investment Group reported no remaining Evoke Pharma position as of Q4 2016 after selling out during the quarter.
  • Chicago Partners Investment Group sold 7 Evoke Pharma shares in Q4 2016, an estimated $2K.
  • Chicago Partners Investment Group first reported a position in Evoke Pharma in Q3 2016 and held it in 1 quarter.
  • Chicago Partners Investment Group's Evoke Pharma position peaked at $2K in Q3 2016.
  • 14 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2016.

Based on Chicago Partners Investment Group's 13F filing for Q4 2016, filed 10 Feb 2017.